<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Calstabins 1 and 2 bind to <z:chebi fb="0" ids="8925">Ryanodine</z:chebi> receptors regulating muscle excitation-contraction coupling </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in <z:chebi fb="0" ids="8925">Ryanodine</z:chebi> receptors affecting their interaction with calstabins lead to different cardiac pathologies </plain></SENT>
<SENT sid="2" pm="."><plain>Animal studies suggest the involvement of calstabins with <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We tested the hypothesis that calstabins mutations may cause <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> in humans screening 186 patients with idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> for genetic alterations in calstabins 1 and 2 genes (FKBP12 and FKBP12.6) </plain></SENT>
<SENT sid="4" pm="."><plain>No missense variant was found </plain></SENT>
<SENT sid="5" pm="."><plain>Five no-coding variations were found but not related to the disease </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: These data corroborate other studies suggesting that mutations in FKBP12 and FKBP12.6 genes are not commonly related to <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac diseases</z:e> </plain></SENT>
</text></document>